vs

Side-by-side financial comparison of Amerant Bancorp Inc. (AMTB) and REPLIGEN CORP (RGEN). Click either name above to swap in a different company.

REPLIGEN CORP is the larger business by last-quarter revenue ($197.9M vs $112.2M, roughly 1.8× Amerant Bancorp Inc.). REPLIGEN CORP runs the higher net margin — 6.7% vs 3.0%, a 3.7% gap on every dollar of revenue. On growth, REPLIGEN CORP posted the faster year-over-year revenue change (13.6% vs 2.9%). Amerant Bancorp Inc. produced more free cash flow last quarter ($129.2M vs $17.6M). Over the past eight quarters, REPLIGEN CORP's revenue compounded faster (14.4% CAGR vs 10.1%).

Amerant Bank is an American bank based in Coral Gables, Florida that is chartered in Florida, with 19 branches in Florida and 55,000 automated teller machines either operating directly or through a network of ATMs.

Repligen Corporation is a global life sciences company devoted to the development and commercialization of innovative bioprocessing technologies and systems that enable efficiencies in the process of manufacturing biological drugs.2025 The company is based in Waltham, Massachusetts,2014 and was incorporated in Delaware in 1981. A public company, Repligen is listed on the NASDAQ exchange under the symbol RGEN. As of 2025, Repligen employs over 1,900 employees globally and serves primarily biop...

AMTB vs RGEN — Head-to-Head

Bigger by revenue
RGEN
RGEN
1.8× larger
RGEN
$197.9M
$112.2M
AMTB
Growing faster (revenue YoY)
RGEN
RGEN
+10.8% gap
RGEN
13.6%
2.9%
AMTB
Higher net margin
RGEN
RGEN
3.7% more per $
RGEN
6.7%
3.0%
AMTB
More free cash flow
AMTB
AMTB
$111.7M more FCF
AMTB
$129.2M
$17.6M
RGEN
Faster 2-yr revenue CAGR
RGEN
RGEN
Annualised
RGEN
14.4%
10.1%
AMTB

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
AMTB
AMTB
RGEN
RGEN
Revenue
$112.2M
$197.9M
Net Profit
$2.7M
$13.3M
Gross Margin
52.5%
Operating Margin
1.7%
9.0%
Net Margin
3.0%
6.7%
Revenue YoY
2.9%
13.6%
Net Profit YoY
-84.0%
143.9%
EPS (diluted)
$0.08
$0.24

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AMTB
AMTB
RGEN
RGEN
Q4 25
$112.2M
$197.9M
Q3 25
$111.4M
$188.8M
Q2 25
$110.3M
$182.4M
Q1 25
$105.4M
$169.2M
Q4 24
$87.6M
$174.1M
Q3 24
$33.3M
$154.9M
Q2 24
$98.8M
$154.1M
Q1 24
$92.5M
$151.3M
Net Profit
AMTB
AMTB
RGEN
RGEN
Q4 25
$2.7M
$13.3M
Q3 25
$14.8M
$14.9M
Q2 25
$23.0M
$14.9M
Q1 25
$12.0M
$5.8M
Q4 24
$16.9M
$-30.3M
Q3 24
$-48.2M
$-654.0K
Q2 24
$5.0M
$3.3M
Q1 24
$10.6M
$2.1M
Gross Margin
AMTB
AMTB
RGEN
RGEN
Q4 25
52.5%
Q3 25
53.2%
Q2 25
50.0%
Q1 25
53.6%
Q4 24
26.1%
Q3 24
50.0%
Q2 24
49.8%
Q1 24
49.5%
Operating Margin
AMTB
AMTB
RGEN
RGEN
Q4 25
1.7%
9.0%
Q3 25
17.1%
8.9%
Q2 25
27.0%
7.6%
Q1 25
14.6%
3.9%
Q4 24
20.6%
-17.7%
Q3 24
-185.8%
-5.1%
Q2 24
6.4%
1.0%
Q1 24
14.6%
1.3%
Net Margin
AMTB
AMTB
RGEN
RGEN
Q4 25
3.0%
6.7%
Q3 25
13.2%
7.9%
Q2 25
20.9%
8.2%
Q1 25
11.3%
3.4%
Q4 24
19.3%
-17.4%
Q3 24
-144.6%
-0.4%
Q2 24
5.0%
2.2%
Q1 24
11.4%
1.4%
EPS (diluted)
AMTB
AMTB
RGEN
RGEN
Q4 25
$0.08
$0.24
Q3 25
$0.35
$0.26
Q2 25
$0.55
$0.26
Q1 25
$0.28
$0.10
Q4 24
$0.53
$-0.55
Q3 24
$-1.43
$-0.01
Q2 24
$0.15
$0.06
Q1 24
$0.31
$0.04

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AMTB
AMTB
RGEN
RGEN
Cash + ST InvestmentsLiquidity on hand
$767.6M
Total DebtLower is stronger
$542.2M
Stockholders' EquityBook value
$938.8M
$2.1B
Total Assets
$9.8B
$2.9B
Debt / EquityLower = less leverage
0.26×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AMTB
AMTB
RGEN
RGEN
Q4 25
$767.6M
Q3 25
$748.7M
Q2 25
$708.9M
Q1 25
$697.2M
Q4 24
$757.4M
Q3 24
$784.0M
Q2 24
$809.1M
Q1 24
$780.6M
Total Debt
AMTB
AMTB
RGEN
RGEN
Q4 25
$542.2M
Q3 25
$537.9M
Q2 25
Q1 25
Q4 24
$525.6M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
AMTB
AMTB
RGEN
RGEN
Q4 25
$938.8M
$2.1B
Q3 25
$944.9M
$2.1B
Q2 25
$924.3M
$2.1B
Q1 25
$906.3M
$2.0B
Q4 24
$890.5M
$2.0B
Q3 24
$902.9M
$2.0B
Q2 24
$734.3M
$2.0B
Q1 24
$738.1M
$2.0B
Total Assets
AMTB
AMTB
RGEN
RGEN
Q4 25
$9.8B
$2.9B
Q3 25
$10.4B
$2.9B
Q2 25
$10.3B
$2.9B
Q1 25
$10.2B
$2.9B
Q4 24
$9.9B
$2.8B
Q3 24
$10.4B
$2.8B
Q2 24
$9.7B
$2.9B
Q1 24
$9.8B
$2.8B
Debt / Equity
AMTB
AMTB
RGEN
RGEN
Q4 25
0.26×
Q3 25
0.26×
Q2 25
Q1 25
Q4 24
0.27×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AMTB
AMTB
RGEN
RGEN
Operating Cash FlowLast quarter
$137.0M
$25.7M
Free Cash FlowOCF − Capex
$129.2M
$17.6M
FCF MarginFCF / Revenue
115.2%
8.9%
Capex IntensityCapex / Revenue
6.9%
4.1%
Cash ConversionOCF / Net Profit
50.71×
1.93×
TTM Free Cash FlowTrailing 4 quarters
$225.2M
$93.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AMTB
AMTB
RGEN
RGEN
Q4 25
$137.0M
$25.7M
Q3 25
$22.7M
$48.1M
Q2 25
$57.6M
$28.6M
Q1 25
$20.2M
$15.0M
Q4 24
$82.2M
$39.2M
Q3 24
$4.2M
$49.3M
Q2 24
$-2.3M
$42.2M
Q1 24
$2.8M
$44.7M
Free Cash Flow
AMTB
AMTB
RGEN
RGEN
Q4 25
$129.2M
$17.6M
Q3 25
$21.7M
$43.4M
Q2 25
$56.3M
$21.5M
Q1 25
$18.0M
$11.4M
Q4 24
$74.8M
$33.6M
Q3 24
$2.6M
$42.3M
Q2 24
$-3.9M
$37.4M
Q1 24
$-694.0K
$36.4M
FCF Margin
AMTB
AMTB
RGEN
RGEN
Q4 25
115.2%
8.9%
Q3 25
19.5%
23.0%
Q2 25
51.0%
11.8%
Q1 25
17.1%
6.8%
Q4 24
85.3%
19.3%
Q3 24
7.8%
27.3%
Q2 24
-3.9%
24.3%
Q1 24
-0.8%
24.0%
Capex Intensity
AMTB
AMTB
RGEN
RGEN
Q4 25
6.9%
4.1%
Q3 25
0.9%
2.5%
Q2 25
1.2%
3.9%
Q1 25
2.1%
2.1%
Q4 24
8.4%
3.2%
Q3 24
4.8%
4.5%
Q2 24
1.5%
3.1%
Q1 24
3.8%
5.5%
Cash Conversion
AMTB
AMTB
RGEN
RGEN
Q4 25
50.71×
1.93×
Q3 25
1.54×
3.23×
Q2 25
2.50×
1.92×
Q1 25
1.69×
2.57×
Q4 24
4.87×
Q3 24
Q2 24
-0.47×
12.70×
Q1 24
0.26×
21.35×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AMTB
AMTB

Other$58.0M52%
Commercial Portfolio Segment$25.7M23%
Commercial Real Estate Portfolio Segment$17.3M15%
Consumer Portfolio Segment$11.1M10%

RGEN
RGEN

Segment breakdown not available.

Related Comparisons